“Since its launch over 20 years ago, we have constantly listened to our customers’ feedback, which has driven continuous design improvements for NovaSure,” said Jan Verstreken, Group President, ...

Benign tissue formations in the muscle tissue of the uterine wall (fibroids), polyps or endometriosis may cause excessively heavy and prolonged menstrual bleeding (menorrhagia). However, the reason ...

MARLBOROUGH, Mass.--(BUSINESS WIRE)--Hologic, Inc. (Nasdaq: HOLX), a global leader in women's health, will launch the NovaSure® V5 global endometrial ablation (GEA) device at the American Association ...

BERKELEY, Calif.--(BUSINESS WIRE)--Channel Medsystems, Inc., a medical device company whose mission is to empower every woman to take control of her health journey, today announced that the first ...

Please provide your email address to receive an email when new articles are posted on . Live birth rates were similar for women with uterine fibroids who underwent radiofrequency ablation or ...

Uterine fibroids (also known as uterine leiomyomas or myomas) are benign tumours of the uterine wall. They can be asymptomatic or cause symptoms including menorrhagia, intermenstrual bleeding, pelvic ...

A recent study has found that 29% of people in Ontario who undergo endometrial ablation will have a subsequent hysterectomy to remove the entire uterus within 15 years. Among women who have been ...

Chronic pelvic pain is commonly described as pain felt below the umbilicus which lasts for at least 6 months. Chronic pelvic pain includes dysmenorrhoea and dyspareunia. Secondary dysmenorrhoea ...

Over the last 20 years, the NovaSure system has built a trusted legacy in GEA. The NovaSure device first received FDA approval in 2001, and by 2018 the NovaSure procedure had been used to treat over 3 ...